Melanoma Cancer Clinical Trials John Stoddard Cancer Center

UnityPoint Clinic Urgent Care - Altoona

Closed Patients
Waiting Now

UnityPoint Clinic Urgent Care - Ingersoll

Closed Patients
Waiting Now

Urgent Care - Ankeny

Closed Patients
Waiting Now

Urgent Care - Lakeview

Closed Patients
Waiting Now

Urgent Care - Merle Hay

Closed Patients
Waiting Now

Urgent Care - Southglen

Closed Patients
Waiting Now

Urgent Care - Urbandale

Closed Patients
Waiting Now

Skin Cancer Research Studies

MELANOMA 

S1616: A Phase II Randomized Study of Nivolumab (NSC-748726) with Ipilimumab (NSC-732442) or Ipilimumab Alone in Advanced Melanoma Patients Refractory to an Anti-PD-1 or Anti-PD-L1Agent. 

MERKEL CELL 

A091605: A Randomized Phase II Study of anti-PD1 antibody [MK-3475 (pembrolizumab)] alone versus anti-PD1 antibody plus Stereotactic Body Radiation therapy in advanced Merkel Cell Carcinoma 

EA6174: A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma 

CUTANEOUS SQUAMOUS CELL 

A091802: Phase II randomized trial of avelumab plus cetuximab versus avelumab alone in advanced cutaneous squamous cell carcinoma of the skin (cSCC)